SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-019241
Filing Date
2023-11-20
Accepted
2023-11-20 16:00:35
Documents
15
Period of Report
2023-11-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nhwk-20231120x8k.htm   iXBRL 8-K 42717
2 EX-99.1 nhwk-20231120xex99d1.htm EX-99.1 17523
3 GRAPHIC nhwk-20231120xex99d1001.jpg GRAPHIC 6775
  Complete submission text file 0001558370-23-019241.txt   229367

Data Files

Seq Description Document Type Size
4 EX-101.SCH nhwk-20231120.xsd EX-101.SCH 4308
5 EX-101.DEF nhwk-20231120_def.xml EX-101.DEF 14029
6 EX-101.LAB nhwk-20231120_lab.xml EX-101.LAB 20098
7 EX-101.PRE nhwk-20231120_pre.xml EX-101.PRE 13693
9 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20231120x8k_htm.xml XML 7154
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 231422694
SIC: 2834 Pharmaceutical Preparations